A new study involving researchers from UW Medicine, Seattle Children's and the Kaiser Permanente Center for Health Research in Portland, Oregon, aims to shed light on the spread of COVID-19 in the region and how well vaccines protect against the
Dr. Shireesha Dhanireddy, a professor of medicine at the University of Washington School of Medicine, says emerging prescription therapeutics are available for high-risk people to treat or prevent COVID-19.
The Food and Drug Administration is giving the green light for people ages 50 and older to receive a second booster shot of a COVID-19 vaccine, or a fourth total dose.
A subvariant of omicron responsible for a wave of new COVID-19 cases in parts of Europe and Asia is also gradually spreading in the United States, including in Washington state.